Breaking News Instant updates and real-time market news.

UNH

UnitedHealth

$250.25

4.6 (1.87%)

, DVA

DaVita

$51.27

1.51 (3.03%)

18:13
06/19/19
06/19
18:13
06/19/19
18:13

FTC approves UnitedHealth's acquisition of DaVita Medical with conditions

Healthcare provider and insurer UnitedHealth Group Incorporated (UNH) and healthcare provider DaVita, Inc. (DVA) have agreed to a settlement to resolve Federal Trade Commission allegations that UnitedHealth Group's proposed $4.3B acquisition of DaVita's DaVita Medical Group will harm competition in healthcare markets in Clark and Nye Counties, Nevada. Under the proposed settlement, no later than 40 days after the acquisition is final, UnitedHealth Group will divest DaVita Medical Group's healthcare provider organization in the Las Vegas Area to Intermountain Healthcare, a Utah-based healthcare provider and insurer. Under the proposed settlement order, in addition to the divestiture obligations, UnitedHealth Group and DaVita are required to: provide transition assistance to Intermountain Healthcare that includes access to and use of intellectual property and business equipment and information; properly transfer all confidential business information; for one year after the divestiture date, provide Intermountain Healthcare with the opportunity to interview and hire employees to fill key information technology and critical services positions in HealthCare Partners of Nevada; and until the divestiture is complete, maintain the assets and marketability of HealthCare Partners of Nevada. The proposed settlement also appoints John P. Harris as the monitor to ensure that UnitedHealth Group and DaVita comply with all of their obligations under the order. If the parties do not fully comply with their divestiture obligations, the order allows the Commission to appoint a divestiture trustee. Concurrently with the proposed settlement, Intermountain Healthcare will divest its minority stake in rival Las Vegas Area MCPO, P3 Health Partners.

UNH

UnitedHealth

$250.25

4.6 (1.87%)

DVA

DaVita

$51.27

1.51 (3.03%)

  • 18

    Jul

UNH UnitedHealth
$250.25

4.6 (1.87%)

05/10/19
05/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. 3D Systems (DDD) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster noting the stock is down 25% this week after posting "lackluster" Q1 results. 2. Jones Lang LaSalle (JLL) upgraded to Buy from Neutral at Goldman Sachs with analyst Andrew Rosivach saying the company's earnings declined in Q1 due to tough comps, but this should reverse quickly. 3. Ford (F) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy stating the company's earnings are starting to hit a "sustainable inflection" due to favorable product cadence in the North America market and its restructuring efforts. 4. Whirlpool (WHR) upgraded to Buy from Neutral at Longbow with analyst David MacGregor seeing earnings upside from better than expected North American margin performance, a "gradually improving" environment in the EMEA and a favorable cyclical turn in Latin America. 5. Anthem (ANTM), Centene (CNC), and UnitedHealth (UNH) upgraded to Buy from Neutral at Citi with analyst Ralph Giacobbe the magnitude of the selloff in managed care stocks on fears of Medicare for All has been "extreme and overdone". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/19
DADA
05/15/19
NO CHANGE
Target $7
DADA
Buy
Fitbit healthcare story 'underappreciated', says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $7 price target on Fitbit (FIT), citing the company's latest partnering announcement with the UnitedHealthcare's (UNH) Motion effort through its Charge 3 tracker device participation. The analyst believes that the announcement is just the "latest example" in Fitbit's integration efforts within the healthcare ecosystem and sees it as a "huge differentiator" within the sector where investors look at products as "merely commodities."
05/16/19
COWN
05/16/19
NO CHANGE
COWN
Move lower in managed care stocks appears overdone, says Cowen
Cowen analyst Charles Rhyee lowered his target multiple for the managed care group slightly from recent historical levels, but said he believes the recent weakness in the space on concerns around "Medicare for All," the rebate rule and the Texas ACA decision appears overdone. The discount for managed care stocks relative to the broader market has risen to a multi-year high, but he argues that underlying market fundamentals are stronger than in the pre-ACA era and Rhyee contends that there is "still plenty of growth left" in the managed care space, particularly in government-sponsored business. Stocks in the group include Anthem (ANTM), Cigna (CI), Centene (CNC), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
05/20/19
MZHO
05/20/19
NO CHANGE
Target $174
MZHO
Neutral
LabCorp price target raised to $174 from $150 at Mizuho
Mizuho analyst Ann Hynes raised her price target for Neutral-rated LabCorp (LH) to $174 from $150 and for Buy-rated Quest Diagnostics (DGX) to $110 from $106. Despite the recent outperformance in the group, both stocks will continue to re-rate higher as investors anticipate the long-term upside potential from UnitedHealth (UNH) lab initiatives, Hynes tells investors in a research note. The analyst thinks UnitedHealth's initiatives to form a preferred lab network and focus on out-of-network lab spend will bring greater pricing transparency to the clinical lab industry. She sees both LabCorp and Quest benefiting over time.
DVA DaVita
$51.27

1.51 (3.03%)

01/08/19
UBSW
01/08/19
UPGRADE
UBSW
Neutral
DaVita upgraded to Neutral from Sell at UBS
01/08/19
UBSW
01/08/19
UPGRADE
Target $59
UBSW
Neutral
UBS upgrades DaVita to Neutral on better risk/reward profile
UBS analyst Whit Mayo upgraded DaVita to Neutral from Sell while lowering his price target for the shares to $59 from $64. The recent weakness in the shares drives a better risk/reward profile, Mayo tells investors in a research note. The analyst, however, continues to sees structural concerns with payer mix and points out that record industry capacity is for sale.
01/09/19
RBCM
01/09/19
NO CHANGE
Target $65
RBCM
Sector Perform
DaVita price target lowered to $65 from $78 at RBC Capital
RBC Capital analyst Frank Morgan lowered his price target on DaVita to $65 and also reduced his FY19 EPS view to $3.93 from $4.12 after its management provided initial FY19 operating income outlook of $1.54B-$1.64B relative to consensus of $1.62B. The analyst notes that the company's near term is likely to be impacted by "industry headline risk, potential margin pressures due to increased scrutiny of dialysis rates, and ongoing labor cost growth", but sees dialysis as a "steady, stable, defensive industry over the long term, with predictable patient volumes and strong cash flows".
02/15/19
BARD
02/15/19
NO CHANGE
Target $70
BARD
Outperform
DaVita price target lowered to $70 from $90 at Baird
Baird analyst Matthew Gillmor lowered his price target on DaVita to $70 from $90 and acknowledged it remains a controversial stock. The analyst said underlying demand appears to be slowing, but that valuation is undemanding and already reflects significant earnings risk. Although Gillmor said his enthusiasm for DaVita has waned recently, he believes it still has a favorable setup and thus maintained his Outperform rating on the shares.

TODAY'S FREE FLY STORIES

SYF

Synchrony

$36.09

0.54 (1.52%)

, PYPL

PayPal

$119.87

1.07 (0.90%)

08:00
07/19/19
07/19
08:00
07/19/19
08:00
Hot Stocks
Synchrony says average active accounts were up 9% in Q2 »

Synchrony (SYF) says it…

SYF

Synchrony

$36.09

0.54 (1.52%)

PYPL

PayPal

$119.87

1.07 (0.90%)

WMT

Walmart

$114.68

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 24

    Jul

  • 15

    Aug

  • 25

    Sep

  • 13

    Nov

NFLX

Netflix

$325.14

-37.36 (-10.31%)

08:00
07/19/19
07/19
08:00
07/19/19
08:00
Options
Netflix call buyer realizes 3% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

SKX

Skechers

$34.75

0.35 (1.02%)

07:59
07/19/19
07/19
07:59
07/19/19
07:59
Recommendations
Skechers analyst commentary  »

Skechers price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$56.27

1.67 (3.06%)

07:55
07/19/19
07/19
07:55
07/19/19
07:55
Hot Stocks
State Street boosts productivity savings for FY19 to 4.5% from 4% »

State Street says it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

WNS

WNS Holdings

$62.34

3.8 (6.49%)

07:53
07/19/19
07/19
07:53
07/19/19
07:53
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

07:52
07/19/19
07/19
07:52
07/19/19
07:52
Recommendations
Microsoft analyst commentary  »

Microsoft still has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

07:51
07/19/19
07/19
07:51
07/19/19
07:51
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WW

WW

$25.18

1.23 (5.14%)

07:49
07/19/19
07/19
07:49
07/19/19
07:49
Upgrade
WW rating change  »

WW upgraded to Buy at DA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$136.29

0.06 (0.04%)

07:49
07/19/19
07/19
07:49
07/19/19
07:49
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

DOW

Dow Inc.

$51.76

0.15 (0.29%)

07:48
07/19/19
07/19
07:48
07/19/19
07:48
Initiation
Dow Inc. initiated  »

Dow Inc. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 24

    Sep

NGVT

Ingevity

07:44
07/19/19
07/19
07:44
07/19/19
07:44
Downgrade
Ingevity rating change  »

Jefferies downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

INDB

Independent Bank

$73.31

0.56 (0.77%)

07:44
07/19/19
07/19
07:44
07/19/19
07:44
Upgrade
Independent Bank rating change  »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

KBR

KBR

$25.28

0.36 (1.44%)

07:43
07/19/19
07/19
07:43
07/19/19
07:43
Upgrade
KBR rating change  »

KBR upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

MDR

McDermott

$10.20

-0.25 (-2.39%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Hot Stocks
McDermott awarded pre-FEED contract by YPF in Argentina »

McDermott has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

ADTN

Adtran

$12.12

-3.72 (-23.48%)

, DTE

DTE Energy

$131.39

1.27 (0.98%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Recommendations
Adtran, DTE Energy analyst commentary at MKM Partners »

Adtran price target…

ADTN

Adtran

$12.12

-3.72 (-23.48%)

DTE

DTE Energy

$131.39

1.27 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

  • 02

    Oct

AXS

Axis Capital

, ACGL

Arch Capital

$38.24

0.12 (0.31%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Recommendations
Axis Capital, Arch Capital, Travelers, Hartford Financial analyst commentary at Buckingham »

Buckingham upgrades Axis…

AXS

Axis Capital

ACGL

Arch Capital

$38.24

0.12 (0.31%)

TRV

Travelers

$152.69

0.27 (0.18%)

HIG

Hartford Financial

$57.90

0.24 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 30

    Jul

  • 31

    Jul

  • 02

    Aug

  • 06

    Aug

07:40
07/19/19
07/19
07:40
07/19/19
07:40
General news
Treasury Market Outlook: Treasuries are a little weaker »

Treasury Market Outlook:…

WNS

WNS Holdings

$62.34

3.8 (6.49%)

07:39
07/19/19
07/19
07:39
07/19/19
07:39
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

07:38
07/19/19
07/19
07:38
07/19/19
07:38
Recommendations
Intuitive Surgical analyst commentary at Canaccord »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

AXP

American Express

$128.40

1.355 (1.07%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Earnings
American Express backs FY19 adj. EPS view of $7.85-$8.35, consensus $8.13 »

Backs FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

EXPO

Exponent

$61.63

0.83 (1.37%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Recommendations
Exponent analyst commentary  »

Exponent price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

STT

State Street

$56.27

1.67 (3.06%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Earnings
State Street reports Q2 EPS $1.42, consensus $1.39 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

WW

WW

$25.18

1.23 (5.14%)

07:36
07/19/19
07/19
07:36
07/19/19
07:36
Upgrade
WW rating change  »

WW upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBBP

Strongbridge Biopharma

$2.77

-0.12 (-4.15%)

07:35
07/19/19
07/19
07:35
07/19/19
07:35
Hot Stocks
Strongbridge Biopharma announces new employment inducement awards »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$128.40

1.355 (1.07%)

07:35
07/19/19
07/19
07:35
07/19/19
07:35
Earnings
American Express reports Q2 EPS $2.07, consensus $2.04 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.